And when you say that you get 7-8x you mean for the weekly average correct? Because that's what I get too. Between 7.5-8.5x on weekly average
Every mid cycle blood I've ever done has come out in that range.
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
And when you say that you get 7-8x you mean for the weekly average correct? Because that's what I get too. Between 7.5-8.5x on weekly average
I would imagine, yes. I have a baseline that I know good test E/C gives me more or less 7-8x. But, of course there's many variables at play. Such as Ai's, HCG, etc.
I understand your points here, BTW.
And when you say that you get 7-8x you mean for the weekly average correct? Because that's what I get too. Between 7.5-8.5x on weekly average
Every mid cycle blood I've ever done has come out in that range.
I think that is exactly what people aren't getting.
I don't have access to Autocad at the moment so I quickly drew this graph up in MS Paint. The graph is just a rough drawing and is not to scale but should help convey the pharmacokinetics.
Red represents the peak and nadir TT levels for once a week dosing and black represents the peak and nadir for 1/2 dose twice a week. Total weekly dose is the same for both dosing regimens and user is at steady state.
As you can see, a full weekly dose results in a higher peak TT and lower nadir than divided doses. Half a dose given twice weekly results lower peaks than full doses given once weekly, but higher nadir levels. Obviously, the lower peak from twice weekly dosing will have a negative impact on the 10X rule. Again, graph is NOT to scale.
Divided doses also result in less fluctuation in serum TT.
I hope this graph makes sense.
Every mid cycle blood I've ever done has come out in that range.
No of course that was not my intent in my post, to discount bloods entirely. Not at all. I am here on Meso for the bloods.
But in light of what I keep reading, especially in this thread, I am wondering if the TT measurement is as important as it is always made out to be, if individual variance can have such a huge effect on it.
Jim, I really am curious HOW much HCG can/will skew the results?Who said ANYTHING about INDIVIDUAL variance?
The problem is relatively simple, people are constantly deviating from the control group by dosing twice weekly, adding an AI, HCG, any ANY other AAS that can result in the offloading of TT from Albumin or SHBG.
If you fellas want reproducible data follow the TRT studies inclusion/exclusion criteria.
Jim
Who said ANYTHING about INDIVIDUAL variance?
The problem is relatively simple, people are constantly deviating from the control group by dosing twice weekly, adding an AI, HCG, any ANY other AAS that can result in the offloading of TT from Albumin or SHBG.
If you fellas want reproducible data follow the TRT studies inclusion/exclusion criteria.
Jim
I think the take home point is mates whom are not following the TRT study criteria, in which those patients who were taking an agent that could effect TT levels were omitted, should expect LESS reliable results.
HCG as used in infertility patients can increase TT levels to normal age matched ranges and a similar effect is seen with AI's.
Of course mates using AAS are NOT matched controls but nonetheless the potential impact of these agents on TT levels should simply not be ignored.
Thanks @Dr JIM
1) My question then is, do we have any amount of (or can we begin to compile some) data on the dose- and protocol-dependent effects of ancillaries and pinning protocols in regards to cycling?
I see that you mentioned some HCG infertility studies.
2) But short of compiling cycle logs from everyone who honestly reports their cycle, protocol, and ancillary use, and comparing that to the TRT studies already published, is there a feasible way to get an idea of this?
1) NIMO!
2) Sure conduct a legitimate study
Haha message received. But even an informal compilation of data might be of some use. Probably for nothing more than satisfying curiosity, though
Completely agree.
I'd just like to collect enough data on split dosing using the same protocol to at least get an average acceptable range of serum TT on a certain dose. With enough data it can be accomplished. But as I said too many deviations.
I getcha...and it'd have to all be data from pharm grade, as well...couldn't get any further useful data from bloods that are already being used to gauge the strength of UGL gear...
But homebrewed raws that were MS/HPLC tested would be sufficient. Pharmacy grade has nothing to do with it. Exact dosage is key.
Question. Shouldnt the RBC be high from the EQ? Or is it still inactive at this stage? Ok i just saw 7 weeks the EQ should be on.